The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats

Japanese Journal of Pharmacology

Volumn 70, Issue 1, 1996, Pages 25-33

  Hattori, Tomohisa ^a   Nagamatsu, Tadashi ^a   Ito, Mikio ^a   Suzuki, Yoshio ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Cellular immunity; Hyperlipidemia; Nephrosis; Puromycin aminonucleoside

Indexed keywords

ANTILIPEMIC AGENT; AZATHIOPRINE; CD4 ANTIGEN; CHOLESTEROL; COLESTYRAMINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; PUROMYCIN AMINONUCLEOSIDE; SIMFIBRATE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; GLOMERULUS; HELPER CELL; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; MONOCYTE; MONONUCLEAR CELL; NEPHROSIS; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN URINE LEVEL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030043094     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.70.25     Document Type: Article

References (24)

1. Ryan GB and Karnovsky MJ: An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8, 219-232 (1975)
2. Thakur V, Walker PD and Shah SV: Evidence suggesting a role for hydroxy radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34, 494-499 (1988)
3. Diamond JR, Bonventre JV and Karnovsky MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29, 478-483 (1986)
4. Harris KPG, Lefkowith JB, Klahr S and Schreiner GF: Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest 86, 1115-1123 (1990)
5. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y and Keane WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37, 880-891 (1990)
6. Koyama A, Fujisaki M, Kobayashi M, Igarashi M and Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40, 453-460 (1991)
7. Gheradi F, Rota E, Calandra S, Genova R and Tamborino A: Relationship among the concentrations of serum lipoprotein and changes in their chemical composition in patient with untreated nephrotic syndrome. Eur J Clin Invest 7, 563-570 (1977)
8. Moorhead JF: Lipids and progressive kidney disease. Kidney Int 39, S35-S40 (1991)
9. Keane WF, Mulcahy WS, Kasiske BL, Kim Y and O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 39, S41-S48 (1991)
10. Preic-Golia L and Peric-Golia M: Aortic and renal lesions in hypercholesterolemic adult, male virgin Sprague-Dawley rats. Atherosclerosis 46, 57-65 (1983)
11. Wellmann KF and Volk BW: Renal lesions in experimental hypercholesterolemia in normal and in subdiabetic rabbits II. Long term studies. Lab Invest 24, 144-155 (1971)
12. French SW, Yamanaka W and Ostwald R: Dietary induced glomerulosclerosis in the guinea pig. Arch Pathol Lab Med 83, 204-210 (1967)
13. Rogners KA, Hoover RL, Castellot JJ, Robinson JM and Karnovsky MJ: Dietary cholesterol-induced changes in macrophage characteristics. Am J Pathol 125, 284-291 (1986)
14. Diamond JR, Pesek I, McCarter MD and Karnovsky MJ: Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia. Am J Pathol 135, 711-718 (1989)
15. Kingsbury FB, Clark CP, Williams G and Post AL: The rapid determination of albumin in urine. J Lab Clin Med 11, 981-989 (1926)
16. Hancock WW, Becker GJ and Atkins RC: A comparison of fixatives and immunohistochemical technic for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol 78, 825-831 (1982)
17. Arima S, Nakayama M, Naito M, Sato T and Takahari K: Significance of mononuclear phagocyte in IgA nephropathy. Kidney Int 39, 684-692 (1990)
18. Hattori T, Nagamatsu T, Ito M and Suzuki Y: Contribution of ED-1 and CD8 antigen positive cells in glomeruli during the course of anti-GBM nephritis. Jpn J Nephrol 36, 20-31 (1994)
19. Shaloub RJ: Pathogenesis of lipoid nephrosis: A disorder of T cell function. Lancet 2, 556-560 (1974)
20. Eyres K, Mallick NP and Taylor G: Evidence for cell-mediated immunity to renal antigens in minimal change nephrotic syndrome. Lancet 1, 1158-1159 (1976)
21. Schreiner GF, Cotran RS and Unanue ER: Modulation of Ia and leukocyte common antigen expression in rats glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest 51, 524-533 (1984)
22. Kasiske BL, O'Donnell MP, Garvis WJ and Keane WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62, 367-378 (1988)
23. Kasiske BL, O'Donnell MP, Cleary MP and Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33, 667-672 (1988)
24. Rabelink AJ, Hene RJ, Erkelens DW, Joles JA and Koomans HA: Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidemia of nephrotic syndrome. Lancet 1, 1335-1338 (1988)